Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2022-10, Vol.174, p.S35-S35
Main Authors: Workman, P., Clarke, P.A., Te Poele, R., Powers, M., Box, G., De Billy, E., De Haven Brandon, A., Hallsworth, A., Hayes, A., McCann, H., Sharp, S., Valenti, M., Raynaud, F.I., Eccles, S.A., Cheeseman, M., Jones, K.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)00893-0